(Q73734846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

HIV-1 entry - an expanding portal for drug discovery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Blair WS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Lin PF

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Meanwell NA

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Wallace OB

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

183-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Primary HIV-1 resistance: a new phase in the epidemic?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

HIV-1 attachment: another look.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

The CD4-gp120 interaction and AIDS pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Role of chemokine receptors in HIV-1 infection and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Chemokines and HIV-1 second receptors: the therapeutic connection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Atomic structure of a thermostable subdomain of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Structural rearrangements in the transmembrane glycoprotein after receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Capture of an early fusion-active conformation of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901484-7

7 January 2021

10.1016/S1359-6446(00)01484-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10790262%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference